The Vyafuser pump maintains a continuous ... While patients with Parkinson’s initially start taking oral drugs like levodopa and carbidopa to manage symptoms, these often fail to control ...

The Vyafuser pump maintains a continuous, steady flow of the drug throughout the day and can be refilled at home by patients or their carers. "People living with advanced Parkinson's disease ...

AbbVie today announced that its two Phase 2 EMPOWER trials investigating emraclidine as a once-daily, oral monotherapy treatment for adults with schizophrenia who are experiencing an acute ...

A MAN got his first organic erection in almost three decades after using a breakthrough gadget to treat erectile dysfunction.

Sep. 24, 2024 — Parkinson's disease, a debilitating nervous system disorder, is treated with medications that sometimes cause impaired decision-making and poor ... Some Diabetes Drugs Tied to ...

Some Diabetes Drugs Tied to Lower Risk of Dementia, Parkinson's Disease Sep. 18, 2024 — A class of drugs for diabetes may be associated with a lower risk of dementia and Parkinson's disease ...

Blind, Randomized, Placebo-controlled, Study of Bezisterim in Subjects with Early Parkinson’s Disease is now fully funded. Favorable capital market conditions last week enabled the company to raise ...

Factors associated with ageing that can increase falls risk include loss of muscle strength and balance, orthostatic hypotension, and visual and functional impairments. Older people may also have ...

This remarkable growth represents a compound annual growth rate (CAGR) of 7.9%, highlighting the increasing demand for innovative drug delivery solutions. Osmotic pumps, known for their versatility ...

More than 54% of people in the United States who take heartburn medications called proton pump inhibitors (PPIs) daily still have acid reflux symptoms. Additionally, PPIs do not work for everyone.

Wegovy Q3 sales total $2.5 bln Beat forecast but group sales weaker than expected Results soothe investor worries over slowing obesity drug demand Shares rose nearly 9%, but later reversed course ...